Log in to save to my catalogue

Malignant Histiocytosis With PD-L1 Expression-Dramatic Response to Nivolumab

Malignant Histiocytosis With PD-L1 Expression-Dramatic Response to Nivolumab

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03959782v1

Malignant Histiocytosis With PD-L1 Expression-Dramatic Response to Nivolumab

About this item

Full title

Malignant Histiocytosis With PD-L1 Expression-Dramatic Response to Nivolumab

Publisher

England: Elsevier, Inc

Journal title

Mayo Clinic proceedings, 2022-07, Vol.97 (7), p.1401-1403

Language

English

Formats

Publication information

Publisher

England: Elsevier, Inc

More information

Alternative Titles

Full title

Malignant Histiocytosis With PD-L1 Expression-Dramatic Response to Nivolumab

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_hal_primary_oai_HAL_hal_03959782v1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03959782v1

Other Identifiers

ISSN

0025-6196

E-ISSN

1942-5546

DOI

10.1016/j.mayocp.2022.05.012

How to access this item